Medicines

We cannot provide detailed information about our prescription medicines on this website, in compliance with regulations.

Our medicines are approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. In some cases, health care professionals and patients can visit local AstraZeneca websites to find out more about our medicines. Please note that in some countries we are not allowed to provide very much, or sometimes any, information on our prescription medicines so you should seek alternative trustworthy sources. Always ask a healthcare professional for advice about medicines.



Reporting of side effects

The safety of our patients is very important to us. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

By reporting any side effects that you may experience, you are helping to provide more information on the safety of our medicines. Report a possible side-effect to AstraZeneca by 'report side-effect' below. If you are based in the UK, you can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.



Cardiovascular, Renal and Metabolic Diseases

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Atacand, Atacand HCT, Atacand Plus

candesartan cilexetil

Brilinta/Brilique

ticagrelor

Bydureon

exenatide

Byetta

exenatide injection

Crestor

rosuvastatin

Farxiga/Forxiga

dapagliflozin

Komboglyze

saxagliptin and metformin HCl

Kombiglyze XR

saxagliptin and metformin XR

Lokelma

Sodium zirconium cyclosilicate

Onglyza

saxagliptin

Plendil, Modip, Splendil, Munobal, Flodil 

felodipine

Qtern

dapagliflozin and saxagliptin

Seloken ZOK, Toprol-XL, Betaloc ZOK

metoprolol succinate

Symlin

pramlintide acetate

Tenormin, Tenormine, Prenormine, Atenol 

atenolol

XIGDUO

dapagliflozin and metformin HCI

XIGDUO XR 

dapagliflozin and metformin HCI extended-release

Zestril

lisinopril dihydrate

Oncology

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Arimidex 

anastrozole

Calquence

acalabrutinib

Casodex, Cosudex

bicalutamide

Faslodex 

fulvestrant

Imfinzi

durvalumab

Iressa

gefitinib

Lynparza

olaparib

Tagrisso

osimertinib

Zoladex

goserelin acetate implant

Infection and Vaccines

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Synagis 

palivizumab

Fluenz Tetra/FluMist Quadrivalent

influenza vaccine live, intra-nasal

Neuroscience

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Diprivan

propofol

EMLA

EMLA

Movantik/Moventig 

naloxegol

Naropin

ropivacaine

Seroquel IR

quetiapine fumarate

Seroquel XR

quetiapine fumarate

Xylocaine

lidocaine

Zomig, Zomig Rapimelt, Zomig Nasal Spray, AscoTop, Zomigon 

zolmitriptan

Respiratory

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Accolate, Accoleit, Vanticon

zafirlukast

Bevespi Aerosphere

glycopyrronium/formoterol fumarate

Bricanyl Respules

terbutaline

Bricanyl Turbuhaler

terbutaline in a dry powder inhaler

Daliresp/Daxas

roflumilast

Duaklir Genuair

aclidinium/formoterol

Eklira Genuair/Tudorza/Bretaris

aclidinium, a LAMA

Fasenra

benralizumab

Oxis Turbuhaler

Oxis Turbuhaler

Pulmicort Respules

budesonide inhalation suspension

Pulmicort Turbuhaler

budesonide

Rhinocort

budesonide

Symbicort pMDI

budesonide/formoterol

Symbicort Turbuhaler

budesonide/formoterol

Gastrointestinal

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Losec, Gastroloc, Mopral, Omepral, Prilosec

omeprazole

Nexium

esomeprazole

Vimovo

naproxen and esomeprazole magnesium


Early access to AstraZeneca investigational medicinal products

We recognise that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enrol in one of our clinical trials. In such circumstances individual patients may be eligible for early access to an AstraZeneca investigational medicinal product.

 


Veeva ID: Z4-17492    

Date of next review: 07/06/2021